arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2013-19-4-326-333arthyper-103Research ArticleОБЗОРREVIEWСОСУДИСТЫЕ КОГНИТИВНЫЕ НАРУШЕНИЯ: ВОЗМОЖНЫЕ МЕХАНИЗМЫ РАЗВИТИЯVASCULAR COGNITIVE IMPAIRMENT: POSSIBLE MECHANISMS OF DEVELOPMENTЗуеваИ. Б.ZuevaI. V,.

Кандидат медицинских наук, заведующая кардиологическим отделением № 1 для больных инфарктом миокарда ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Минздрава России.

Контактная информация: ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Министер-ства здравоохранения Российской Федерации, ул. Аккуратова, д. 2, Санкт-Петербург, Россия, 197341. Тел. 8 (812) 702–68–11.  E-mail: iravit@yandex.ru (Зуева Ирина Борисовна).

Corresponding author: Almazov Federal Heart, Blood and Endocrinology Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. Phone: 8 (812) 702–68–11. E-mail: iravit@yandex.ru (Irina B. Zueva, MD, PhD, the Head of the Cardiology Department № 2 at Almazov Federal Heart, Blood and Endocrinology Centre).

iravit@yandex.ruФедеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-ПетербургРоссияAlmazov Federal Heart, Blood and Endocrinology Centre, St PetersburgRussian Federation201328082013194326333Copyright © Зуева И.Б., 20132013Зуева И.Б.Zueva I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/103

Распространенность сосудистых когнитивных нарушений возрастает по мере старения населения. Учитывая растущее медицинское, социальное и экономическое значение сосудистых когнитивных нарушений, их профилактика и лечение являются важными приоритетами в настоящее время. Выявление механизмов развития сосудистых когнитивных нарушений позволит целенаправленно проводить первичную и вторичную профилактику, а также осуществлять своевременную терапию.

The prevalence of vascular cognitive impairment increases with the population ageing. Given the growing medical, social and economic signiicance of vascular cognitive impairment, its prevention and treatment are important priorities nowadays. Understanding the mechanisms of vascular cognitive impairment contributes to the effective primary and secondary prevention, as well as to proper treatment.

сосудистые когнитивные нарушениямеханизмы развитияvascular cognitive impairmentmechanismsReferencesLobo A., Launer L.J., Fratiglioni L. et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group // Neurology. — 2000. — Vol. 54, № 11, Suppl. 5. — P. 4–9.Lobo A., Launer L.J., Fratiglioni L. et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group // Neurology. — 2000. — Vol. 54, № 11, Suppl. 5. — P. 4–9.Wahlund L.E.T., Gauthier S. Vascular cognitive impairment in clinical practice // Cambridge, UK: Cambridge University Press. — 2009. — 254 p.Wahlund L.E.T., Gauthier S. Vascular cognitive impairment in clinical practice // Cambridge, UK: Cambridge University Press. — 2009. — 254 p.He W., Sengupta M., Velkoff V.A., DeBarros K.A. U.S. Census Bureau, Current Population Reports, P23–209, 65+ in the United States: 2005 // U.S. Government Printing Ofice, Washington, DC. — 2005. — 243 p.He W., Sengupta M., Velkoff V.A., DeBarros K.A. U.S. Census Bureau, Current Population Reports, P23–209, 65+ in the United States: 2005 // U.S. Government Printing Ofice, Washington, DC. — 2005. — 243 p.Ukraintseva S., Sloan F., Arbeev K., Yashin A. Increasing rates of dementia at time of declining mortality from stroke // Stroke. — 2006. — Vol. 37, № 5. — P. 1155–1159.Ukraintseva S., Sloan F., Arbeev K., Yashin A. Increasing rates of dementia at time of declining mortality from stroke // Stroke. — 2006. — Vol. 37, № 5. — P. 1155–1159.Hachinski V.C., Bowler J.V. Vascular dementia // Neurology. — 1993. — Vol. 43, № 10. — P. 2159–2160.Hachinski V.C., Bowler J.V. Vascular dementia // Neurology. — 1993. — Vol. 43, № 10. — P. 2159–2160.Bowler J.V., Steenhuis R., Hachinski V. Conceptual background to vascular cognitive impairment // Alzheimer Dis. Assoc. Disord. — 1999. — Vol. 13, Suppl. 3. — P. 30–37.Bowler J.V., Steenhuis R., Hachinski V. Conceptual background to vascular cognitive impairment // Alzheimer Dis. Assoc. Disord. — 1999. — Vol. 13, Suppl. 3. — P. 30–37.O’Brien J.T., Erkinjuntti T., Reisberg B. et al. Vascular cognitive impairment // Lancet Neurol. — 2003. — Vol. 2, № 2. — P. 89–98.O’Brien J.T., Erkinjuntti T., Reisberg B. et al. Vascular cognitive impairment // Lancet Neurol. — 2003. — Vol. 2, № 2. — P. 89–98.Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments // Lancet Neurol. — 2008. — Vol. 7, № 3. — P. 246–255.Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments // Lancet Neurol. — 2008. — Vol. 7, № 3. — P. 246–255.Rockwood K., Brown M., Merry H., Sketris I., Fisk J. Societal costs of vascular cognitive impairment in older adults // Stroke. — 2002. — Vol. 33, № 6. — P. 1605–1609.Rockwood K., Brown M., Merry H., Sketris I., Fisk J. Societal costs of vascular cognitive impairment in older adults // Stroke. — 2002. — Vol. 33, № 6. — P. 1605–1609.Sicras A., Rejas J., Arco S. et al. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer’s dementia in a population setting // Dement. Geriatr. Cogn. Disord. — 2005. — Vol. 19, № 5–6. — P. 305–315.Sicras A., Rejas J., Arco S. et al. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer’s dementia in a population setting // Dement. Geriatr. Cogn. Disord. — 2005. — Vol. 19, № 5–6. — P. 305–315.Hill J., Fillit H., Shah S.N., Valle M.C., Futterman R. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population // J. Alzheimers Dis. — 2005. — Vol. 8, № 1. — P. 43–50.Hill J., Fillit H., Shah S.N., Valle M.C., Futterman R. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population // J. Alzheimers Dis. — 2005. — Vol. 8, № 1. — P. 43–50.Boyle P.A., Cahn-Weiner D. Assessment and prediction of functional impairment in vascular dementia // Expert Rev. Neurother. — 2004. — Vol. 4, № 1. — P. 109–114.Boyle P.A., Cahn-Weiner D. Assessment and prediction of functional impairment in vascular dementia // Expert Rev. Neurother. — 2004. — Vol. 4, № 1. — P. 109–114.Nys G.M., Zandvoort M.J., Worp H.B. et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke // J. Neurol. Sci. — 2006. — Vol. 247, № 2. — P. 149–156.Nys G.M., Zandvoort M.J., Worp H.B. et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke // J. Neurol. Sci. — 2006. — Vol. 247, № 2. — P. 149–156.Langa K.M., Foster N.L., Larson E.B. Mixed dementia: emerging concepts and therapeutic implications // J. Am. Med. Assoc. — 2004. — Vol. 292, № 23. — P. 2901–2908.Langa K.M., Foster N.L., Larson E.B. Mixed dementia: emerging concepts and therapeutic implications // J. Am. Med. Assoc. — 2004. — Vol. 292, № 23. — P. 2901–2908.Jin Y.P., Legge S., Ostbye T., Feightner J.W., Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population // Alzheimers Dement. — 2006. — Vol. 2, № 3. — P. 171–178.Jin Y.P., Legge S., Ostbye T., Feightner J.W., Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population // Alzheimers Dement. — 2006. — Vol. 2, № 3. — P. 171–178.Knopman D.S., Roberts R.O., Geda Y.E. et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study // Arch. Neurol. — 2009. — Vol. 66, № 5. — P. 614–619.Knopman D.S., Roberts R.O., Geda Y.E. et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study // Arch. Neurol. — 2009. — Vol. 66, № 5. — P. 614–619.Tatemichi T.K., Desmond D.W., Paik M. et al. Clinical determinants of dementia related to stroke // Ann. Neurol. — 1993. — Vol. 33, № 6. — P. 568–575.Tatemichi T.K., Desmond D.W., Paik M. et al. Clinical determinants of dementia related to stroke // Ann. Neurol. — 1993. — Vol. 33, № 6. — P. 568–575.Desmond D.W., Moroney J.T., Sano M., Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study // Stroke. — 2002. — Vol. 33, № 9. — P. 2254–2260.Desmond D.W., Moroney J.T., Sano M., Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study // Stroke. — 2002. — Vol. 33, № 9. — P. 2254–2260.Desmond D.W., Moroney J.T., Paik M.C. et al. Frequency and clinical determinants of dementia after ischemic stroke // Neurology. — 2000. — Vol. 54, № 5. — P. 1124–1131.Desmond D.W., Moroney J.T., Paik M.C. et al. Frequency and clinical determinants of dementia after ischemic stroke // Neurology. — 2000. — Vol. 54, № 5. — P. 1124–1131.Snowdon D.A., Greiner L.H., Mortimer J.A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study // J. Am. Med. Assoc. — 1997. — Vol. 277, № 10. —P. 813–817.Snowdon D.A., Greiner L.H., Mortimer J.A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study // J. Am. Med. Assoc. — 1997. — Vol. 277, № 10. —P. 813–817.Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease // Lancet. — 1999. — Vol. 354, № 9182. — P. 919–920.Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease // Lancet. — 1999. — Vol. 354, № 9182. — P. 919–920.Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons // Neurology. — 2007. — Vol. 69, № 24. — P. 2197–2204.Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons // Neurology. — 2007. — Vol. 69, № 24. — P. 2197–2204.Skoog I., Nilsson L., Palmertz B. et al. A population-based study of dementia in 85-year-olds // N. Engl. J. Med. — 1993. — Vol. 328, № 3. — P. 153–158.Skoog I., Nilsson L., Palmertz B. et al. A population-based study of dementia in 85-year-olds // N. Engl. J. Med. — 1993. — Vol. 328, № 3. — P. 153–158.Ahtiluoto S., Polvikoski T., Peltonen M. et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study // Neurology. — 2010. — Vol. 75, № 13. —P. 1195–1202.Ahtiluoto S., Polvikoski T., Peltonen M. et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study // Neurology. — 2010. — Vol. 75, № 13. —P. 1195–1202.Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers // Neurology. — 1992. — Vol. 42, № 3, Pt. 1. — P. 473–480.Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers // Neurology. — 1992. — Vol. 42, № 3, Pt. 1. — P. 473–480.Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop // Neurology. — 1993. — Vol. 43, № 2. — P. 250–260.Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop // Neurology. — 1993. — Vol. 43, № 2. — P. 250–260.Diagnostic and statistical manual of mental disorders. — 4. — Washington, DC: APA Press., 1994.Diagnostic and statistical manual of mental disorders. — 4. — Washington, DC: APA Press., 1994.The ICD-10 classiication of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. — Switzer-land: WHO., 1992. — 267 p.The ICD-10 classiication of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. — Switzer-land: WHO., 1992. — 267 p.The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for researchа. — Geneva, 1993. — 263 p.The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for researchа. — Geneva, 1993. — 263 p.Яхно Н.Н., Захаров В.В. Сосудистые когнитивные расстройства // Рос. мед. журн. — 2005. — Т. 13., № 12. — C. 789–793 / Yakhno N.N., Zakharov V.V. Vascular cognitive disorders // Russian Medical Journal [Rossiyskiy Meditsinskiy Zhurnal]. — 2005. — Vol. 13, № 12. — P. 789–793 [Russian].Яхно Н.Н., Захаров В.В. Сосудистые когнитивные расстройства // Рос. мед. журн. — 2005. — Т. 13., № 12. — C. 789–793 / Yakhno N.N., Zakharov V.V. Vascular cognitive disorders // Russian Medical Journal [Rossiyskiy Meditsinskiy Zhurnal]. — 2005. — Vol. 13, № 12. — P. 789–793 [Russian].Levine D.A., Langa K.M. Vascular cognitive impairment: disease mechanisms and therapeutic implication // Neurotherapeutics. — 2011. — Vol. 8, № 3. — P. 361–373.Levine D.A., Langa K.M. Vascular cognitive impairment: disease mechanisms and therapeutic implication // Neurotherapeutics. — 2011. — Vol. 8, № 3. — P. 361–373.O’Donnell M.J., Xavier D., Liu L. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study // Lancet. — 2010. — Vol. 376, № 9735. — P. 112–123.O’Donnell M.J., Xavier D., Liu L. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study // Lancet. — 2010. — Vol. 376, № 9735. — P. 112–123.Yoshitake T., Kiyohara Y., Kato I. et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a deined elderly Japanese population: the Hisayama Study // Neurology. — 1995. — Vol. 45, № 6. — P. 1161–1168.Yoshitake T., Kiyohara Y., Kato I. et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a deined elderly Japanese population: the Hisayama Study // Neurology. — 1995. — Vol. 45, № 6. — P. 1161–1168.Kuller L.H., Lopez O.L., Jagust W.J. et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study // Neurology. — 2005. — Vol. 64, № 9. — P. 1548–1552.Kuller L.H., Lopez O.L., Jagust W.J. et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study // Neurology. — 2005. — Vol. 64, № 9. — P. 1548–1552.Solomon A., Kivipelto M., Wolozin B. et al. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later // Dement. Geriatr. Cogn. Disord. — 2009. — Vol. 28, № 1. — P. 75–80.Solomon A., Kivipelto M., Wolozin B. et al. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later // Dement. Geriatr. Cogn. Disord. — 2009. — Vol. 28, № 1. — P. 75–80.Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort // Am. J. Epidemiol. — 2001. — Vol. 154, № 7. — P. 635–641.Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort // Am. J. Epidemiol. — 2001. — Vol. 154, № 7. — P. 635–641.Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia // Curr. Alzheimer Res. — 2007. — Vol. 4, № 2. — P. 103–109.Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia // Curr. Alzheimer Res. — 2007. — Vol. 4, № 2. — P. 103–109.Ravaglia G., Forti P., Lucicesare A. et al. Physical activity and dementia risk in the elderly: indings from a prospective Italian study // Neurology. — 2008. — Vol. 70, № 19, Pt. 2. — P. 1786–1794.Ravaglia G., Forti P., Lucicesare A. et al. Physical activity and dementia risk in the elderly: indings from a prospective Italian study // Neurology. — 2008. — Vol. 70, № 19, Pt. 2. — P. 1786–1794.Зуева И.Б., Ванаева К.И., Санец Е.Л. и др. Взаимосвязь факторов сердечно-сосудистого риска с когнитивными функциями у пациентов среднего возраста // Артериальная гипертензия. — 2011. — Т. 17, № 5. — С. 432–440. / Zueva I.B., Vanaeva K.I., Sanez E.L. et al. Association of cognitive functionЗуева И.Б., Ванаева К.И., Санец Е.Л. и др. Взаимосвязь факторов сердечно-сосудистого риска с когнитивными функциями у пациентов среднего возраста // Артериальная гипертензия. — 2011. — Т. 17, № 5. — С. 432–440. / Zueva I.B., Vanaeva K.I., Sanez E.L. et al. Association of cognitive functionwith cardiovascular risk factors in middle age individuals // Arterial Hypertension [Arterialnaya Gipertenziya]. — 2011. — Vol. 17, № 5. — P. 432–440 [Russian].with cardiovascular risk factors in middle age individuals // Arterial Hypertension [Arterialnaya Gipertenziya]. — 2011. — Vol. 17, № 5. — P. 432–440 [Russian].Schiffrin E.L. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment // Am. J. Hypertens. — 2004. — Vol. 17, № 12, Pt. 1. — P. 1192–1200.Schiffrin E.L. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment // Am. J. Hypertens. — 2004. — Vol. 17, № 12, Pt. 1. — P. 1192–1200.Izzard A.S., Rizzoni D., Agabiti-Rosei E., Heagerty A.M. Small artery structure and hypertension: adaptive changes and target organ damage // J. Hypertens. — 2005. — Vol. 23, № 2. — P. 247–250.Izzard A.S., Rizzoni D., Agabiti-Rosei E., Heagerty A.M. Small artery structure and hypertension: adaptive changes and target organ damage // J. Hypertens. — 2005. — Vol. 23, № 2. — P. 247–250.Intengan H.D., Thibault G., Li J.S., Schiffrin E.L. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptorIntengan H.D., Thibault G., Li J.S., Schiffrin E.L. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptorantagonism and converting enzyme inhibition // Circulation. — 1999. — Vol. 100, № 22. — P. 2267–2275.antagonism and converting enzyme inhibition // Circulation. — 1999. — Vol. 100, № 22. — P. 2267–2275.Antonios T.F.T., Singer D.R.J., Markandu N.D. Structural skin capillary rarefaction in essential hypertension // Hypertension. — 1999. — Vol. 33. — P. 998–1001.Antonios T.F.T., Singer D.R.J., Markandu N.D. Structural skin capillary rarefaction in essential hypertension // Hypertension. — 1999. — Vol. 33. — P. 998–1001.Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension — a new target for treatment? // Circulation. — 2001. — Vol. 104, № 6. — P. 735–740.Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension — a new target for treatment? // Circulation. — 2001. — Vol. 104, № 6. — P. 735–740.Le Noble F.A., Stassen F.R., Hacking W.J., Struijker-Boudier H.A. Angiogenesis and hypertension // J. Hypertens. — 1998. — Vol. 16, № 11. — P. 1563–1572.Le Noble F.A., Stassen F.R., Hacking W.J., Struijker-Boudier H.A. Angiogenesis and hypertension // J. Hypertens. — 1998. — Vol. 16, № 11. — P. 1563–1572.Feihl F., Liaudet L., Waeber B., Levt B.I. Hypertension. A disease of the microcirculation? // Hypertension. — 2006. — Vol. 48, № 6. — P. 1–7.Feihl F., Liaudet L., Waeber B., Levt B.I. Hypertension. A disease of the microcirculation? // Hypertension. — 2006. — Vol. 48, № 6. — P. 1–7.De Leeuw F.E., de Groot J.C., Oudkerk M. et al. Hypertension and cerebral white matter lesions in a prospective cohort study // Brain. — 2002. — Vol. 125, № 4. — P. 765–772.De Leeuw F.E., de Groot J.C., Oudkerk M. et al. Hypertension and cerebral white matter lesions in a prospective cohort study // Brain. — 2002. — Vol. 125, № 4. — P. 765–772.Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inlammation, cholesterol, and misfolded proteins // Lancet. — 2004. — Vol. 363, № 9415. — P. 1139–1146.Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inlammation, cholesterol, and misfolded proteins // Lancet. — 2004. — Vol. 363, № 9415. — P. 1139–1146.Iadecola C., Park L., Capone C. Threats to the mind: aging, amyloid, and hypertension. — Stroke. — 2009. — Vol. 40, № 3, suppl. — P. 40–44.Iadecola C., Park L., Capone C. Threats to the mind: aging, amyloid, and hypertension. — Stroke. — 2009. — Vol. 40, № 3, suppl. — P. 40–44.Iadecola C., Gorelick P.B. Converging pathogenic mechanisms in vascular and neurodegenerative dementia // Stroke. — 2003. — Vol. 34, № 2. — P. 335–337.Iadecola C., Gorelick P.B. Converging pathogenic mechanisms in vascular and neurodegenerative dementia // Stroke. — 2003. — Vol. 34, № 2. — P. 335–337.Middleton L.E., Yaffe K. Promising strategies for the prevention of dementia // Arch. Neurol. — 2009. — Vol. 66, № 10. — P. 1210–1215.Middleton L.E., Yaffe K. Promising strategies for the prevention of dementia // Arch. Neurol. — 2009. — Vol. 66, № 10. — P. 1210–1215.Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged // Arch. Neurol. — 2009. — Vol. 66, № 3. — P. 300–305.Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged // Arch. Neurol. — 2009. — Vol. 66, № 3. — P. 300–305.Wardlaw J.M., Sandercock P.A., Dennis M.S. et al. Isbreakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? // Stroke. — 2003. — Vol. 34, № 3. — P. 806–812.Wardlaw J.M., Sandercock P.A., Dennis M.S. et al. Isbreakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? // Stroke. — 2003. — Vol. 34, № 3. — P. 806–812.Murray A.M. The brain and the kidney connection: а model of accelerated vascular cognitive impairment // Neurology. — 2009. — Vol. 73, № 12. — P. 916–917.Murray A.M. The brain and the kidney connection: а model of accelerated vascular cognitive impairment // Neurology. — 2009. — Vol. 73, № 12. — P. 916–917.Puccio D., Novo G., Baiamonte V. et al. Atrial ibrillation and mild cognitive impairment: what correlation? // Minerva Cardioangiol. — 2009. — Vol. 57, № 2. — P. 143–150.Puccio D., Novo G., Baiamonte V. et al. Atrial ibrillation and mild cognitive impairment: what correlation? // Minerva Cardioangiol. — 2009. — Vol. 57, № 2. — P. 143–150.Oijen M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia // Stroke. — 2005. —Vol. 36, № 12. — P. 2637–2641.Oijen M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia // Stroke. — 2005. —Vol. 36, № 12. — P. 2637–2641.Gallacher J., Bayer A., Lowe G. et al. Is sticky blood badfor the brain?: Hemostatic and inlammatory systems and dementia in the Caerphilly Prospective Study // Arterioscler. Thromb. Vasc. Biol. — 2010. — Vol. 30, № 3. — P. 599–604.Gallacher J., Bayer A., Lowe G. et al. Is sticky blood badfor the brain?: Hemostatic and inlammatory systems and dementia in the Caerphilly Prospective Study // Arterioscler. Thromb. Vasc. Biol. — 2010. — Vol. 30, № 3. — P. 599–604.Ivan C.S., Seshadri S., Beiser A. et al. Dementia after stroke: the Framingham Study // Stroke. — 2004. — Vol. 35, № 6. — P. 1264–1268.Ivan C.S., Seshadri S., Beiser A. et al. Dementia after stroke: the Framingham Study // Stroke. — 2004. — Vol. 35, № 6. — P. 1264–1268.Zuliani G., Guerra G., Ranzini M. et al. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia // Int. J. Geriatr. Psychiatry. — 2007. — Vol. 22, № 4. — P. 305–311.Zuliani G., Guerra G., Ranzini M. et al. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia // Int. J. Geriatr. Psychiatry. — 2007. — Vol. 22, № 4. — P. 305–311.Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease trends // Neuroscience. — 1994. — Vol. 17, № 12. — P. 525–530.Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease trends // Neuroscience. — 1994. — Vol. 17, № 12. — P. 525–530.Strittmatter W.J., Saunders A.M., Schmechel D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90, № 5. — P. 1977–1981.Strittmatter W.J., Saunders A.M., Schmechel D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90, № 5. — P. 1977–1981.Sing C.F., Davington J. Role of apolipoprotein E genetic polymorphism in determining normal plasma lipid and lipoprotein variation // Am. J. Hum. Gen. — 1985. — Vol. 37, № 2. —Р. 268–285.Sing C.F., Davington J. Role of apolipoprotein E genetic polymorphism in determining normal plasma lipid and lipoprotein variation // Am. J. Hum. Gen. — 1985. — Vol. 37, № 2. —Р. 268–285.Davignon J., Gregg R.E., Sing S.F. Apolipoprotein E polymorphism and atherosclerosis // Arteriosclerosis. — 1988. — Vol. 8, № 1. — P. 1–21.Davignon J., Gregg R.E., Sing S.F. Apolipoprotein E polymorphism and atherosclerosis // Arteriosclerosis. — 1988. — Vol. 8, № 1. — P. 1–21.Terry J.G., Howard G., Mercuri M., Bond M.G., Crouse J.R. 3rd. Apolipoprotein E polymorphism is associated with segment-speciic extracranial carotid artery intima-media thickening // Stroke. — 1996. — Vol. 27, № 10. — P. 155–175.Terry J.G., Howard G., Mercuri M., Bond M.G., Crouse J.R. 3rd. Apolipoprotein E polymorphism is associated with segment-speciic extracranial carotid artery intima-media thickening // Stroke. — 1996. — Vol. 27, № 10. — P. 155–175.Cattin L., Fisicaro M., Tonizzo M. еt al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis deined by ultrasonography in asymptomatic adults // Arterioscl. Thromb. Vasc. Biol. — 1997. — Vol. 17, № 1. — P. 91–97.Cattin L., Fisicaro M., Tonizzo M. еt al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis deined by ultrasonography in asymptomatic adults // Arterioscl. Thromb. Vasc. Biol. — 1997. — Vol. 17, № 1. — P. 91–97.Vauhkonen I., Nisknen L., Ryynanen M. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects // Diabet. Med. — 1997. — Vol. 14, № 9. — P. 748–756.Vauhkonen I., Nisknen L., Ryynanen M. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects // Diabet. Med. — 1997. — Vol. 14, № 9. — P. 748–756.Hanon O., Girerd X., Luong V., Jeunemaitre X., Laurent S., Safar M.E. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults // J. Hyperten. — 2000. — Vol. 18, № 4. — P. 431–436.Hanon O., Girerd X., Luong V., Jeunemaitre X., Laurent S., Safar M.E. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults // J. Hyperten. — 2000. — Vol. 18, № 4. — P. 431–436.Hillen T., Niecza R., Munzmerg H. et al. Carotid atherosclerosis, vascular risk proile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin Ageing Study // J. Intern. Med. — 2000. — Vol. 247, № 6. — P. 679–688.Hillen T., Niecza R., Munzmerg H. et al. Carotid atherosclerosis, vascular risk proile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin Ageing Study // J. Intern. Med. — 2000. — Vol. 247, № 6. — P. 679–688.Baum L., Lam L.C., Kwok T. et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia // Dement. Geriatr. Cogn. Disord. — 2006. — Vol. 22, № 4. — P. 301–305.Baum L., Lam L.C., Kwok T. et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia // Dement. Geriatr. Cogn. Disord. — 2006. — Vol. 22, № 4. — P. 301–305.Kuller L.H., Lopez O.L., Newman A. et al. Risk factors for dementia in the cardiovascular health cognition study // Neuroepidemiol. — 2003. — Vol. 22, № 1. — P. 13–22.Kuller L.H., Lopez O.L., Newman A. et al. Risk factors for dementia in the cardiovascular health cognition study // Neuroepidemiol. — 2003. — Vol. 22, № 1. — P. 13–22.Elkins J.S., Johnston C.S., Elad Ziv E. et al. Methylenetetrahydrofolate Reductase C677T Polymorphism and Cognitive Function in Older // Am. J. Epidemiol. — 2007. — Vol. 166, № 6. — P. 672–678.Elkins J.S., Johnston C.S., Elad Ziv E. et al. Methylenetetrahydrofolate Reductase C677T Polymorphism and Cognitive Function in Older // Am. J. Epidemiol. — 2007. — Vol. 166, № 6. — P. 672–678.Khandanpour N., Willis G., Meyer F.J. et al. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis // J. Vasc. Surg. — 2009. — Vol. 49, № 3. — P. 711–718.Khandanpour N., Willis G., Meyer F.J. et al. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis // J. Vasc. Surg. — 2009. — Vol. 49, № 3. — P. 711–718.Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in conirmed Alzheimer disease // Arch. Neurol. — 1998. — Vol. 55, № 11. — P. 1449–1455.Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in conirmed Alzheimer disease // Arch. Neurol. — 1998. — Vol. 55, № 11. — P. 1449–1455.McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland // Stroke. — 2002. — Vol. 33, № 10. — P. 2351–2356.McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland // Stroke. — 2002. — Vol. 33, № 10. — P. 2351–2356.Datta S., Pal S. K., Mazumdar H., Bhandari B., Bhattacherjee S., Pandit S. Homocysteine and cerebrovascular accidents // J. Indian Med. Assoc. — 2009. — Vol. 107, № 6. — P. 345–346.Datta S., Pal S. K., Mazumdar H., Bhandari B., Bhattacherjee S., Pandit S. Homocysteine and cerebrovascular accidents // J. Indian Med. Assoc. — 2009. — Vol. 107, № 6. — P. 345–346.Seshadri S., Beiser A., Selhub J. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease // N. Engl. J. Med. — 2002. — Vol. 346, № 7. — P. 476–483.Seshadri S., Beiser A., Selhub J. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease // N. Engl. J. Med. — 2002. — Vol. 346, № 7. — P. 476–483.Tsai S.J., Hong C.J., Yeh H.L. et al. Heterozygote аdvantage of the MTHFR C677T рolymorphism on speciic cognitive performance in elderly chinese males without dementia // Dement. Geriatr. Cogn. Disord. — 2011. — Vol. 32, № 3. — P. 159–163.Tsai S.J., Hong C.J., Yeh H.L. et al. Heterozygote аdvantage of the MTHFR C677T рolymorphism on speciic cognitive performance in elderly chinese males without dementia // Dement. Geriatr. Cogn. Disord. — 2011. — Vol. 32, № 3. — P. 159–163.Margues G.M.D., Krieger J.E., Casarini D.E. Angiotensinconverting enzyme: a possible genetic marker // Hypertension. — 2002. — Vol. 20, suppl. 4. — 263 p.Margues G.M.D., Krieger J.E., Casarini D.E. Angiotensinconverting enzyme: a possible genetic marker // Hypertension. — 2002. — Vol. 20, suppl. 4. — 263 p.Jeunemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen // Cell. — 1992. — Vol. 71, № 1. — P. 169–180.Jeunemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen // Cell. — 1992. — Vol. 71, № 1. — P. 169–180.Liu H., Liu M., Li W. Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis // J. Geriatr. Psych. Neurol. — 2009. — Vol. 22, № 1. — P. 10–22.Liu H., Liu M., Li W. Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis // J. Geriatr. Psych. Neurol. — 2009. — Vol. 22, № 1. — P. 10–22.Liu M.E., Tsai S.J., Lu T. No association of angiotensin I converting enzyme I/D polymorphism with domain-speciic cognitive function in aged men without dementia // Neuromol. Med. — 2011. — Vol. 13, № 3. — P. 212–216.Liu M.E., Tsai S.J., Lu T. No association of angiotensin I converting enzyme I/D polymorphism with domain-speciic cognitive function in aged men without dementia // Neuromol. Med. — 2011. — Vol. 13, № 3. — P. 212–216.Zhang Z., Deng L., Bai F. Alteration of resting brain function by genetic variation in angiotensin converting enzyme in amnestic-type mild cognitive impairment of Chinese Han // Behav. Brain Res. — 2010. — Vol. 208, № 2. — P. 619–625.Zhang Z., Deng L., Bai F. Alteration of resting brain function by genetic variation in angiotensin converting enzyme in amnestic-type mild cognitive impairment of Chinese Han // Behav. Brain Res. — 2010. — Vol. 208, № 2. — P. 619–625.Zhang Z., Deng L., Bai F. ACE I/D polymorphism affects cognitive function and gray-matter volume in amnestic mild cognitive impairment // Behav. Brain Res. — 2011. — Vol. 218, № 1. — P. 114–120.Zhang Z., Deng L., Bai F. ACE I/D polymorphism affects cognitive function and gray-matter volume in amnestic mild cognitive impairment // Behav. Brain Res. — 2011. — Vol. 218, № 1. — P. 114–120.Bai F., Zhang Z., Watson D.R. et al. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment // Biol. Psych. — 2009. — Vol. 65, № 11. — P. 951–958.Bai F., Zhang Z., Watson D.R. et al. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment // Biol. Psych. — 2009. — Vol. 65, № 11. — P. 951–958.Groop L. Genetics of the metabolic syndrome // Br. J. Nutr. — 2000. — Vol. 83, suppl. 1. — P. S39–S84.Groop L. Genetics of the metabolic syndrome // Br. J. Nutr. — 2000. — Vol. 83, suppl. 1. — P. S39–S84.Sierra C., Gomez-Angelats E., Poch E. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension // Hypertension. — 2002. — Vol. 39, № 2,Sierra C., Gomez-Angelats E., Poch E. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension // Hypertension. — 2002. — Vol. 39, № 2,Pt. 2. — P. 343–347.Pt. 2. — P. 343–347.Mykkanen L., Kuusisto J., Pyorala K., Laakso M. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects // Diabetologia. — 1993. — Vol. 36, № 6. — P. 553–559.Mykkanen L., Kuusisto J., Pyorala K., Laakso M. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects // Diabetologia. — 1993. — Vol. 36, № 6. — P. 553–559.Nicholls M.G., Richards A.M., Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease // J. Hum. Hypertens. — 1998. — Vol. 12, № 5. — P. 295–299.Nicholls M.G., Richards A.M., Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease // J. Hum. Hypertens. — 1998. — Vol. 12, № 5. — P. 295–299.Hsieh M.C., Lin S.R., Hsieh T.J. Increased frequency of angiotensin-converting enzyme D/D genotype in patients with type 2 diabetes in Taiwan // Nephrol. Dial. Transplant. — 2000. — Vol. 15, № 7. — P. 1008–1013.Hsieh M.C., Lin S.R., Hsieh T.J. Increased frequency of angiotensin-converting enzyme D/D genotype in patients with type 2 diabetes in Taiwan // Nephrol. Dial. Transplant. — 2000. — Vol. 15, № 7. — P. 1008–1013.Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system // Curr. Hypertens. Rep. — 2008. — Vol. 10, № 2. — P. 93–98.Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system // Curr. Hypertens. Rep. — 2008. — Vol. 10, № 2. — P. 93–98.Van Swieten J.C., Geyskes G.G., Derix M.M.A. Hypertension in the elderly is associated with white matter lesions and cognitive decline // Ann. Neurol. — 1991. — Vol. 30, № 6. — P. 825–830.Van Swieten J.C., Geyskes G.G., Derix M.M.A. Hypertension in the elderly is associated with white matter lesions and cognitive decline // Ann. Neurol. — 1991. — Vol. 30, № 6. — P. 825–830.Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels // J. Clin. Invest. — 1990. — Vol. 86, № 4. — P. 1343–1346.Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels // J. Clin. Invest. — 1990. — Vol. 86, № 4. — P. 1343–1346.Staessen J.A., Ginocchio G., Petrov V. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk // J. Hyperten. — 1997. — Vol. 15, № 12, Pt. 2. — P. 1579–1592.Staessen J.A., Ginocchio G., Petrov V. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk // J. Hyperten. — 1997. — Vol. 15, № 12, Pt. 2. — P. 1579–1592.Sharma P. Meta-analysis of the ACE gene in ischemic stroke // J. Neurol. Neurosurg. Psych. — 1998. — Vol. 64. — P. 227–230.Sharma P. Meta-analysis of the ACE gene in ischemic stroke // J. Neurol. Neurosurg. Psych. — 1998. — Vol. 64. — P. 227–230.Kario K., Kanai N., Saito K., Nago N., Matsuo T., Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives // Circulation. — 1996. — Vol. 93, № 9. — P. 1630–1633.Kario K., Kanai N., Saito K., Nago N., Matsuo T., Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives // Circulation. — 1996. — Vol. 93, № 9. — P. 1630–1633.Niu T., Yang J., Wang B. et al. Angiotensinogen genepolymorphisms M235T/T174 M: no excess transmission to hypertensive Chinese // Hypertension. — 1999. — Vol. 33, № 2. — P. 698–702.Niu T., Yang J., Wang B. et al. Angiotensinogen genepolymorphisms M235T/T174 M: no excess transmission to hypertensive Chinese // Hypertension. — 1999. — Vol. 33, № 2. — P. 698–702.Taittonen L., Kontula K., Kainulainen K. Angiotensinogen converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension,and childhood blood pressure // Am. J. Hypertens. — 1999. — Vol. 12. — P. 858–866.Taittonen L., Kontula K., Kainulainen K. Angiotensinogen converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension,and childhood blood pressure // Am. J. Hypertens. — 1999. — Vol. 12. — P. 858–866.Saab Y.B., Gard P.R., Overall A.D. The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population // J. Renin-Angiotensin-Aldosterone Syst. — 2011. — Vol. 12, № 4. — P. 588–594.Saab Y.B., Gard P.R., Overall A.D. The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population // J. Renin-Angiotensin-Aldosterone Syst. — 2011. — Vol. 12, № 4. — P. 588–594.Lenkei Z., Palkovits M., Corvol P. et al. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: A functional neuroanatomical review // Frontiers Neuroendocrinol. — 1997. — Vol. 18, № 9, Pt. 1. — P. 383–439.Lenkei Z., Palkovits M., Corvol P. et al. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: A functional neuroanatomical review // Frontiers Neuroendocrinol. — 1997. — Vol. 18, № 9, Pt. 1. — P. 383–439.Hajjar I., Kritchevsky S., Newman A.B. Renin angiotensin system gene polymorphisms modify angiotensin converting enzyme (ACE) inhibitors’ effect on cognitive function: the Health, Aging and Body Composition Study // J. Am. Geriatr. Society. — 2010. — Vol. 58, № 6. — P. 1035–1042.Hajjar I., Kritchevsky S., Newman A.B. Renin angiotensin system gene polymorphisms modify angiotensin converting enzyme (ACE) inhibitors’ effect on cognitive function: the Health, Aging and Body Composition Study // J. Am. Geriatr. Society. — 2010. — Vol. 58, № 6. — P. 1035–1042.

The authors declare that there are no conflicts of interest present.